AQR Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $314K | Buy |
135,766
+27,867
| +26% | +$64.4K | ﹤0.01% | 2854 |
|
|
2025
Q1 | $150K | Buy |
107,899
+82,545
| +326% | +$115K | ﹤0.01% | 2942 |
|
|
2024
Q4 | $43.9K | Sell |
25,354
-44,117
| -64% | -$76.3K | ﹤0.01% | 2818 |
|
|
2024
Q3 | $140K | Buy |
+69,471
| New | +$140K | ﹤0.01% | 2622 |
|
|
2022
Q3 | – | Sell |
-10,134
| Closed | -$38K | – | 2323 |
|
|
2022
Q2 | $38K | Buy |
+10,134
| New | +$38K | ﹤0.01% | 2146 |
|